دواعي استعمال برينوريلاكس 30مجم 10 كبسولة ممتد المفعول

Cyclobenzaprine 30 mg extended-release capsules, pack of 10 (Liptis, Egypt).

• Adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions; short-term use only (up to 2-3 weeks).الفئة: AdultsDailyMed (U.S. National Library of Medicine)

• Most common (>=3% and greater than placebo): dry mouth, dizziness, fatigue, constipation, nausea, dyspepsia, somnolence.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity to any component; concomitant MAO inhibitors or within 14 days after their discontinuation; acute recovery phase of myocardial infarction; arrhythmias, heart block or conduction disturbances, congestive heart failure; hyperthyroidism.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)

• Potentially life-threatening serotonin syndrome reported with SSRIs, SNRIs, TCAs, tramadol, bupropion, meperidine, verapamil or MAO inhibitors.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)

• MAO inhibitorsContraindicated: hyperpyretic crisis, seizures and deaths reported with concomitant use.DailyMed (U.S. National Library of Medicine)
• SSRIs, SNRIs, TCAs, tramadol, bupropion, meperidine, verapamilRisk of serotonin syndrome.DailyMed (U.S. National Library of Medicine)

• Case-report data have not identified a drug-associated risk of major birth defects, miscarriage or adverse maternal/fetal outcomes; decreased pup weight and survival in rats at >=3x MRHD.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
• No data on presence in human or animal milk, effects on the breastfed infant or milk production.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)

• Relieves skeletal muscle spasm of local origin; acts primarily within the CNS at the brain stem rather than at the neuromuscular junction (US AMRIX label 12.1).